TScan Therapeutics, Inc. (TCRX) Misses Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.17 -0.02 (10.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $26.80 | |||
| Open | $0.19 | 52 Week Low | $23.00 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $0.00 | |||
| Volume | 333,158 | |||||
